Celyad Oncology SA (CYAD.BR) Stock Price
€0.301 0%
to add to portfolio
AI Score
-
Alternative
4 -
Fundamental
1 -
Technical
2
Our AI Score rates companies on a scale from 0 to 10, based on alternative data points such as web traffic, app downloads, and job postings — combined with financial health indicators and technical signals. Scores are designed to reflect relative strength or weakness across these factors, helping users compare companies and track changes over time.
Sign up to get access to more historical data and insights on Celyad Oncology SA, AI stock picks, stock alerts and much more.
CYAD.BR AI Stock Analysis
AI stock analysis for CYAD.BR is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Celyad Oncology SA (CYAD.BR) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
Celyad Oncology SA (CYAD.BR) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Celyad Oncology SA (CYAD.BR), currently trading at €0.301, will... Sign up to access price prediction.
About CYAD.BR
-
Celyad Oncology SA, a clinical-stage biopharmaceutical company, focuses on the discovery and development of chimeric antigen receptor T (CAR-T) cell therapies for the treatment of cancer.
-
Symbol
CYAD.BR
-
Market
EURONEXT
-
Industry
Biotechnology
-
Market Cap
12.5M
Similar Stocks
 |
Valneva SE VLA.PA |
€3.82 0.5% |
5 |
 |
Financière de Tubize SA TUB.BR |
€167.2 1.2% |
8 |
 |
OSE Immunotherapeutics SA OSE.PA |
€5.95 0.7% |
6 |
 |
UCB SA UCB.BR |
€205.5 0.9% |
6 |
 |
Innate Pharma S.A. IPH.PA |
€1.82 5.5% |
5 |
CYAD.BR Alternative Data
Web Traffic
Celyad Oncology SA receives an estimated 4951 monthly visitors to celyad.com, which is up by 233.2% over the last month.
-
Web Traffic
4951
-
Change from Previous Month
233.2%
-
3 Month Change
387.8%
-
YoY Change
387.8%
Twitter Followers
Celyad Oncology SA has 2,270 Twitter Followers on its main Twitter (also known as X) account, which is down by -0.1% over the last month.
-
Twitter Followers
2270
-
Daily Change
0%
-
1 Month Change
0.1%
-
3 Month Change
0.2%
-
YoY Change
0.2%
Youtube Subscribers
Celyad Oncology SA has 493 subscribers on its main Youtube channel.
-
Youtube Subscribers
493
-
Daily Change
0.2%
-
1 Month Change
0%
-
3 Month Change
0%
-
YoY Change
0%
Job Postings
Celyad Oncology SA currenly has an estimated 0 open job postings.
-
Job Postings
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
-
YoY Change
0%
LinkedIn Employees
According to LinkedIn, Celyad Oncology SA has 27 employees, down by -10% over the last month.
-
LinkedIn Employees
27
-
Daily Change
12.9%
-
1 Month Change
10%
-
3 Month Change
10%
-
YoY Change
10%
Business Outlook
According to employee reviews, the business outlook among employees at Celyad Oncology SA is 28 out of 100 (bearish).
-
Business Outlook
28
-
Change from Previous Month
0%
-
3 Month Change
24.3%
-
YoY Change
24.3%
News Mentions
Celyad Oncology SA was mentioned 0 times in the news yesterday.
-
News Mentions
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
-
YoY Change
0%
Reddit Mentions
Celyad Oncology SA has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
0
-
1 Month Change
0%
-
3 Month Change
0%
CYAD.BR Financials
CYAD.BR Key Metrics
-
Total Revenue
€172K
-
Net Income
-€2.8M
-
Earnings per Share
-€0.0671
-
Free cash flow
-€2.8M
-
EBITDA
-€2.6M
-
EBITDA Ratio
-15.1279
-
Total Assets
€9.9M
CYAD.BR 2-year Revenue & Income
CYAD.BR 2-year Free Cash Flow
CYAD.BR Technicals
CYAD.BR SMA
CYAD.BR RSI
FAQ
What's the current price of Celyad Oncology SA (CYAD.BR) Stock?
The price of an Celyad Oncology SA (CYAD.BR) share is €0.301.
What's the market cap of Celyad Oncology SA?
The current market cap of Celyad Oncology SA is 12.5M.
What are some stocks similar to Celyad Oncology SA (CYAD.BR) that investors often compare it to?
Celyad Oncology SA (CYAD.BR) is often compared to similar stocks such as Valneva SE, Financière de Tubize SA, OSE Immunotherapeutics SA, UCB SA and Innate Pharma S.A..
What is the forecast for Celyad Oncology SA's stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Celyad Oncology SA's stock price to be around €0.284 in 2026. Starting from the current price of €0.301, this represents a 5.6% change in price, indicating a bearish outlook for the stock.
How to buy Celyad Oncology SA (CYAD.BR) Stock?
Celyad Oncology SA stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Celyad Oncology SA shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.